We are live on
!
Find out more
Ultragenyx Pharmaceutical
RARE
RARE
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AIM
251
Aigen Investment Management
New York
| – | -$240K | -6,732 | Closed |
|
252
Prudential Financial
Newark,
New Jersey
| – | -$228K | -6,409 | Closed |
|
253
D.E. Shaw & Co
New York
| – | -$219K | -6,152 | Closed |
|
|
HT
254
Headlands Technologies
Chicago,
Illinois
| – | -$119K | -3,351 | Closed |
|
|
EIM
255
Essex Investment Management
Boston,
Massachusetts
| – | -$52.8K | -1,481 | Closed |
|
|
CG
256
Cutler Group
San Francisco,
California
| – | -$36K | -1,010 | Closed |
|
|
SSG
257
Summit Securities Group
New York
| – | -$23K | -657 | Closed |
|
258
Loomis, Sayles & Company
Boston,
Massachusetts
| – | -$5K | -152 | Closed |
|
|
IA
259
IFP Advisors
Tampa,
Florida
| – | -$2.6K | -73 | Closed |
|
|
CA
260
Crewe Advisors
Salt Lake City,
Utah
| – | -$107 | -3 | Closed |
|